2011 - 2021年胃肠病学随机对照试验中A92名女性作者

C. S. Liu, Z. X. Lin, K. Kroeker
{"title":"2011 - 2021年胃肠病学随机对照试验中A92名女性作者","authors":"C. S. Liu, Z. X. Lin, K. Kroeker","doi":"10.1093/jcag/gwac036.092","DOIUrl":null,"url":null,"abstract":"Abstract Background Although tremendous strides have been made in the participation of women in medicine, female continues to be underrepresented in leadership positions and higher-level academic medicine. An important factor in determining career advancement in academic medicine is the quality and quantity of an individual’s scholarly publications. To date, no study has looked at female authorship in gastroenterology (GI) randomized control trials (RCTs), which remains the gold standard for evaluating intervention effectiveness. Purpose The primary outcome is to assess female authorship in gastroenterology randomized control trials from 2011 to 2021, and the secondary outcome is to assess female authorship within GI subspecialty RCT publications. Method In this observational study, the gender of the first and last author of gastroenterology RCTs from January 1, 2011 to December 31, 2021 was assessed. Python (v3.8.12) was used to extract publication data from PubMed. A validated algorithm, genderize.io, was used to determine gender. Author first names that cannot be determined by the algorithm were manually searched on publicly-available profiles. Result(s) A total of 5690 original gastroenterology RCTs were included from January 1, 2011 to December 31, 2021. The gender of the first and senior authors of the papers was determined for 5668 (99.6%) first authors and 5656 (99.4%) senior authors. Overall, 1937 (34.1%) of the first authors and 1138 (20.0%) of senior authors were female. There was an increase in the proportion of female first authors over the past decade, from 25.4% in 2011 to 37.8% in 2021 (p<0.05). For senior authors, there was a more gradual increase in female authorship from 14.2% in 2011 to 21.6% in 2021 (p<0.05). (Figure 1) Within GI subspecialties, 612 RCTs were included for inflammatory bowel disease, 1143 RCTs were included for hepatology, and 1856 RCTs were included for therapeutic endoscopy from January 1, 2011 to December 31, 2021. Further analysis will be performed to determine the gender trend for GI subspecialties. Image Conclusion(s) Female authorship in gastroenterology RCTs has increased from 2011 to 2021, although the rate of senior authorship has increased to a slower extent compared to first authors. Across all years, female authorship in gastroenterology RCTs has been lower than males. Please acknowledge all funding agencies by checking the applicable boxes below None Disclosure of Interest None Declared","PeriodicalId":17263,"journal":{"name":"Journal of the Canadian Association of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A92 FEMALE AUTHORSHIP IN GASTROENTEROLOGY RANDOMIZED CONTROL TRIALS: 2011 - 2021\",\"authors\":\"C. S. Liu, Z. X. Lin, K. Kroeker\",\"doi\":\"10.1093/jcag/gwac036.092\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Background Although tremendous strides have been made in the participation of women in medicine, female continues to be underrepresented in leadership positions and higher-level academic medicine. An important factor in determining career advancement in academic medicine is the quality and quantity of an individual’s scholarly publications. To date, no study has looked at female authorship in gastroenterology (GI) randomized control trials (RCTs), which remains the gold standard for evaluating intervention effectiveness. Purpose The primary outcome is to assess female authorship in gastroenterology randomized control trials from 2011 to 2021, and the secondary outcome is to assess female authorship within GI subspecialty RCT publications. Method In this observational study, the gender of the first and last author of gastroenterology RCTs from January 1, 2011 to December 31, 2021 was assessed. Python (v3.8.12) was used to extract publication data from PubMed. A validated algorithm, genderize.io, was used to determine gender. Author first names that cannot be determined by the algorithm were manually searched on publicly-available profiles. Result(s) A total of 5690 original gastroenterology RCTs were included from January 1, 2011 to December 31, 2021. The gender of the first and senior authors of the papers was determined for 5668 (99.6%) first authors and 5656 (99.4%) senior authors. Overall, 1937 (34.1%) of the first authors and 1138 (20.0%) of senior authors were female. There was an increase in the proportion of female first authors over the past decade, from 25.4% in 2011 to 37.8% in 2021 (p<0.05). For senior authors, there was a more gradual increase in female authorship from 14.2% in 2011 to 21.6% in 2021 (p<0.05). (Figure 1) Within GI subspecialties, 612 RCTs were included for inflammatory bowel disease, 1143 RCTs were included for hepatology, and 1856 RCTs were included for therapeutic endoscopy from January 1, 2011 to December 31, 2021. Further analysis will be performed to determine the gender trend for GI subspecialties. Image Conclusion(s) Female authorship in gastroenterology RCTs has increased from 2011 to 2021, although the rate of senior authorship has increased to a slower extent compared to first authors. Across all years, female authorship in gastroenterology RCTs has been lower than males. Please acknowledge all funding agencies by checking the applicable boxes below None Disclosure of Interest None Declared\",\"PeriodicalId\":17263,\"journal\":{\"name\":\"Journal of the Canadian Association of Gastroenterology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Canadian Association of Gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/jcag/gwac036.092\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Canadian Association of Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jcag/gwac036.092","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

尽管女性在医学领域的参与已经取得了巨大的进步,但女性在领导职位和更高水平的学术医学中的代表性仍然不足。决定学术医学职业发展的一个重要因素是个人学术出版物的质量和数量。迄今为止,还没有研究关注胃肠病学(GI)随机对照试验(rct)中的女性作者,这仍然是评估干预有效性的金标准。主要结局是评估2011年至2021年胃肠病学随机对照试验中的女性作者,次要结局是评估GI亚专科RCT出版物中的女性作者。方法在本观察性研究中,评估2011年1月1日至2021年12月31日胃肠病学随机对照试验的第一作者和最后作者的性别。使用Python (v3.8.12)从PubMed提取发布数据。一个有效的算法,性别区分。Io是用来确定性别的。算法无法确定的作者的名字是在公开的个人资料中手动搜索的。结果(5)2011年1月1日至2021年12月31日共纳入5690项胃肠病学随机对照试验。5668名(99.6%)第一作者和5656名(99.4%)高级作者确定了论文第一作者和高级作者的性别。第一作者中有1937人(34.1%)为女性,高级作者中有1138人(20.0%)为女性。在过去十年中,女性第一作者的比例从2011年的25.4%增加到2021年的37.8% (p<0.05)。在资深作者中,女性作者比例从2011年的14.2%逐渐上升到2021年的21.6% (p<0.05)。(图1)在GI亚专科中,2011年1月1日至2021年12月31日,炎症性肠病纳入了612项rct,肝病纳入了1143项rct,治疗性内窥镜纳入了1856项rct。将进行进一步分析以确定GI亚专科的性别趋势。从2011年到2021年,胃肠病学随机对照试验的女性作者数量有所增加,尽管与第一作者相比,高级作者的比例增长速度较慢。多年来,在胃肠病学随机对照试验中,女性作者一直低于男性。请勾选以下适用的方框,确认所有资助机构
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A92 FEMALE AUTHORSHIP IN GASTROENTEROLOGY RANDOMIZED CONTROL TRIALS: 2011 - 2021
Abstract Background Although tremendous strides have been made in the participation of women in medicine, female continues to be underrepresented in leadership positions and higher-level academic medicine. An important factor in determining career advancement in academic medicine is the quality and quantity of an individual’s scholarly publications. To date, no study has looked at female authorship in gastroenterology (GI) randomized control trials (RCTs), which remains the gold standard for evaluating intervention effectiveness. Purpose The primary outcome is to assess female authorship in gastroenterology randomized control trials from 2011 to 2021, and the secondary outcome is to assess female authorship within GI subspecialty RCT publications. Method In this observational study, the gender of the first and last author of gastroenterology RCTs from January 1, 2011 to December 31, 2021 was assessed. Python (v3.8.12) was used to extract publication data from PubMed. A validated algorithm, genderize.io, was used to determine gender. Author first names that cannot be determined by the algorithm were manually searched on publicly-available profiles. Result(s) A total of 5690 original gastroenterology RCTs were included from January 1, 2011 to December 31, 2021. The gender of the first and senior authors of the papers was determined for 5668 (99.6%) first authors and 5656 (99.4%) senior authors. Overall, 1937 (34.1%) of the first authors and 1138 (20.0%) of senior authors were female. There was an increase in the proportion of female first authors over the past decade, from 25.4% in 2011 to 37.8% in 2021 (p<0.05). For senior authors, there was a more gradual increase in female authorship from 14.2% in 2011 to 21.6% in 2021 (p<0.05). (Figure 1) Within GI subspecialties, 612 RCTs were included for inflammatory bowel disease, 1143 RCTs were included for hepatology, and 1856 RCTs were included for therapeutic endoscopy from January 1, 2011 to December 31, 2021. Further analysis will be performed to determine the gender trend for GI subspecialties. Image Conclusion(s) Female authorship in gastroenterology RCTs has increased from 2011 to 2021, although the rate of senior authorship has increased to a slower extent compared to first authors. Across all years, female authorship in gastroenterology RCTs has been lower than males. Please acknowledge all funding agencies by checking the applicable boxes below None Disclosure of Interest None Declared
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
296
审稿时长
10 weeks
期刊最新文献
Motivations behind complementary and alternative medicine use in patients with Crohn's disease and ulcerative colitis. Correction to: Quality of life, clinical outcomes and cost utilization of endoscopic therapy in patients with Barrett's esophagus and early esophageal cancer-an 8-year Canadian experience. An incidental choledochoduodenal fistula discovered during gastroscopy The usefulness of head computed tomography in patients with known cirrhosis presenting to emergency department with suspected hepatic encephalopathy. Quality of life, clinical outcomes and cost utilization of endoscopic therapy in patients with Barrett's esophagus and early esophageal cancer-an 8-year Canadian experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1